| scholarly article | Q13442814 |
| P6179 | Dimensions Publication ID | 1036481505 |
| P356 | DOI | 10.1007/S12325-013-0067-7 |
| P698 | PubMed publication ID | 24194362 |
| P50 | author | Roger S McIntyre | Q88039086 |
| P2093 | author name string | André F Carvalho | |
| Rodrigo B Mansur | |||
| Celina S Liu | |||
| P2860 | cites work | The preventable causes of death in the United States: comparative risk assessment of dietary, lifestyle, and metabolic risk factors | Q21563399 |
| Novel modulator for endothelial adhesion molecules: adipocyte-derived plasma protein adiponectin | Q22010955 | ||
| White matter tractography in bipolar disorder and schizophrenia | Q28295103 | ||
| Diet-induced insulin resistance in mice lacking adiponectin/ACRP30 | Q28511676 | ||
| Leptin modulates the T-cell immune response and reverses starvation-induced immunosuppression | Q28594263 | ||
| Leptin and the regulation of body weight in mammals | Q29615976 | ||
| The hormone resistin links obesity to diabetes | Q29616100 | ||
| Inflammation and its discontents: the role of cytokines in the pathophysiology of major depression | Q29617326 | ||
| Obesity and respiratory hospitalizations during influenza seasons in Ontario, Canada: a cohort study | Q30405999 | ||
| Leptin: a potential novel antidepressant | Q30476721 | ||
| Frontotemporal alterations in pediatric bipolar disorder: results of a voxel-based morphometry study | Q30993466 | ||
| Mitochondrial dysfunction as the molecular basis of bipolar disorder: therapeutic implications. | Q31088436 | ||
| The role of mitochondrial dysfunction in bipolar disorder | Q31100649 | ||
| Obesity and weight gain in adulthood and telomere length | Q33588124 | ||
| A voxel-based diffusion tensor imaging study of white matter in bipolar disorder | Q33611102 | ||
| Medical and substance use comorbidity in bipolar disorder | Q33835811 | ||
| A new concept in neurodegeneration: TNFalpha is a silencer of survival signals | Q33863128 | ||
| The new '5-HT' hypothesis of depression: cell-mediated immune activation induces indoleamine 2,3-dioxygenase, which leads to lower plasma tryptophan and an increased synthesis of detrimental tryptophan catabolites (TRYCATs), both of which contribute | Q34025130 | ||
| The tempted brain eats: pleasure and desire circuits in obesity and eating disorders | Q34032576 | ||
| Cognitive dysfunction in psychiatric disorders: characteristics, causes and the quest for improved therapy | Q34147129 | ||
| Amygdala and hippocampal volumes in adolescents and adults with bipolar disorder | Q34282011 | ||
| Resistin and adiponectin in major depression: the association with free cortisol and effects of antidepressant treatment | Q46959936 | ||
| Weight gain occurs after onset of bipolar illness in overweight bipolar patients | Q47310353 | ||
| Obesity-associated cognitive decline: excess weight affects more than the waistline | Q47440188 | ||
| Decreased brain-derived neurotrophic factor in medicated and drug-free bipolar patients | Q47715435 | ||
| Reduced brain leptin in patients with major depressive disorder and in suicide victims | Q48435457 | ||
| Microstructural white matter changes in euthymic bipolar patients: a whole-brain diffusion tensor imaging study. | Q48511794 | ||
| Brain abnormalities in human obesity: a voxel-based morphometric study | Q48613933 | ||
| Limbic and corpus callosum aberrations in adolescents with bipolar disorder: a tract-based spatial statistics analysis | Q48647467 | ||
| Serum brain-derived neurotrophic factor is decreased in bipolar disorder during depressive and manic episodes | Q48649203 | ||
| Increased levels of adipokines in bipolar disorder | Q48793507 | ||
| Cortical white matter microstructural abnormalities in bipolar disorder | Q48827889 | ||
| Fronto-thalamo-striatal gray and white matter volumes and anisotropy of their connections in bipolar spectrum illnesses | Q48935413 | ||
| Do Canada and the United States differ in prevalence of depression and utilization of services? | Q50182036 | ||
| Personality traits and childhood trauma as correlates of metabolic risk factors: the Netherlands Study of Depression and Anxiety (NESDA). | Q50605515 | ||
| Increased body mass index makes an impact on brain white-matter integrity in adults with remitted first-episode mania. | Q50706849 | ||
| The load of short telomeres is increased and associated with lifetime number of depressive episodes in bipolar II disorder. | Q50788732 | ||
| Meta-analysis of neuropsychological functioning in euthymic bipolar disorder: an update and investigation of moderator variables. | Q50790550 | ||
| The effect of overweight/obesity on cognitive function in euthymic individuals with bipolar disorder. | Q51008916 | ||
| Childhood treatment with psychotropic medication and development of comorbid medical conditions in adolescent-onset bipolar disorder. | Q51854870 | ||
| Association between obesity and depression in Canadians. | Q51863016 | ||
| White matter abnormalities observed in bipolar disorder: a diffusion tensor imaging study. | Q51900828 | ||
| White matter abnormalities in bipolar disorder and schizophrenia detected using diffusion tensor magnetic resonance imaging | Q57316787 | ||
| Obesity in Patients With Bipolar Disorder | Q57452985 | ||
| Kynurenine pathway in major depression: Evidence of impaired neuroprotection | Q58835693 | ||
| Increased neurotrophin-3 in drug-free subjects with bipolar disorder during manic and depressive episodes | Q58950514 | ||
| A randomized, double-blind, controlled trial evaluating the effect of intranasal insulin on neurocognitive function in euthymic patients with bipolar disorder | Q34308807 | ||
| Two British women studies replicated the association between the Val66Met polymorphism in the brain-derived neurotrophic factor (BDNF) and BMI. | Q34326949 | ||
| The impact of statins on psychological wellbeing: a systematic review and meta-analysis | Q34498512 | ||
| ACRP30/adiponectin: an adipokine regulating glucose and lipid metabolism | Q34537657 | ||
| Replicative aging, telomeres, and oxidative stress | Q34614407 | ||
| Relationship of depression to diabetes types 1 and 2: epidemiology, biology, and treatment | Q35189666 | ||
| Cytokine-induced sickness behaviour: a neuroimmune response to activation of innate immunity. | Q35908588 | ||
| Psychiatric and medical comorbidities of bipolar disorder | Q36021272 | ||
| Brain-derived neurotrophic factor as a regulator of systemic and brain energy metabolism and cardiovascular health | Q36139978 | ||
| Lipid signaling in neural plasticity, brain repair, and neuroprotection | Q36217327 | ||
| Effective connectivity of a reward network in obese women | Q36231526 | ||
| Can bipolar disorder be viewed as a multi-system inflammatory disease? | Q36401142 | ||
| Obesity: the disease | Q36527630 | ||
| Can body mass index help predict outcome in patients with bipolar disorder? | Q36532159 | ||
| Approaching the shared biology of obesity and depression: the stress axis as the locus of gene-environment interactions | Q36553056 | ||
| Increased body mass index is associated with a global and distributed decrease in white matter microstructural integrity | Q36652882 | ||
| Molecular genetics of bipolar disorder and depression. | Q36713347 | ||
| Correlates of treatment response in depressed older adults with bipolar disorder | Q36753982 | ||
| The immune-mediated alteration of serotonin and glutamate: towards an integrated view of depression | Q36800963 | ||
| The role of Coenzyme Q in mitochondrial electron transport | Q36813585 | ||
| Medical comorbidity in bipolar disorder: re-prioritizing unmet needs | Q36841349 | ||
| Associations of leukocyte telomere length with body anthropometric indices and weight change in Chinese women | Q36913351 | ||
| Associations between suicide attempts and elevated bedtime salivary cortisol levels in bipolar disorder | Q36933018 | ||
| Health status of individuals with serious mental illness | Q37075921 | ||
| Obesity and vulnerability of the CNS. | Q37234576 | ||
| Leptin regulates striatal regions and human eating behavior | Q37338748 | ||
| Lower orbital frontal white matter integrity in adolescents with bipolar I disorder | Q37354271 | ||
| An expanded view of energy homeostasis: neural integration of metabolic, cognitive, and emotional drives to eat. | Q37395143 | ||
| Cancer incidence in a sample of Maryland residents with serious mental illness | Q37427364 | ||
| Examination of the relationship between obesity and suicidal ideation | Q37603580 | ||
| Hypothalamic inflammation and energy homeostasis: resolving the paradox | Q37613162 | ||
| Relation of regional gray and white matter volumes to current BMI and future increases in BMI: a prospective MRI study | Q37696745 | ||
| Brain volume abnormalities and neurocognitive deficits in diabetes mellitus: points of pathophysiological commonality with mood disorders? | Q37730612 | ||
| Pathways underlying neuroprogression in bipolar disorder: focus on inflammation, oxidative stress and neurotrophic factors | Q37799094 | ||
| Mood disorders and obesity: understanding inflammation as a pathophysiological nexus | Q37821806 | ||
| New drug targets in depression: inflammatory, cell-mediated immune, oxidative and nitrosative stress, mitochondrial, antioxidant, and neuroprogressive pathways. And new drug candidates--Nrf2 activators and GSK-3 inhibitors. | Q37978196 | ||
| Oxidative stress and inflammation interactions in human obesity | Q37986642 | ||
| Obesity and suicide risk in adults--a systematic review | Q38032658 | ||
| Obesity in bipolar disorder: an overview | Q38035727 | ||
| The neuroprotective effects of GLP-1: possible treatments for cognitive deficits in individuals with mood disorders | Q38045690 | ||
| Mitochondria and endocrine function of adipose tissue | Q38061275 | ||
| Is bipolar disorder an inflammatory condition? The relevance of microglial activation | Q38063784 | ||
| Risk of venous thromboembolism during treatment with antipsychotic agents | Q38068538 | ||
| Role of the Toll Like receptor (TLR) radical cycle in chronic inflammation: possible treatments targeting the TLR4 pathway | Q38084202 | ||
| Obesity and psychiatric disorders: commonalities in dysregulated biological pathways and their implications for treatment. | Q38107749 | ||
| Childhood maltreatment and obesity: systematic review and meta-analysis | Q38108153 | ||
| Cytokines in bipolar disorder vs. healthy control subjects: a systematic review and meta-analysis | Q38114586 | ||
| High-fat meal induced postprandial inflammation. | Q38121048 | ||
| Impaired CNS leptin action is implicated in depression associated with obesity | Q38335664 | ||
| Cognitive endophenotypes of bipolar disorder: a meta-analysis of neuropsychological deficits in euthymic patients and their first-degree relatives | Q40062404 | ||
| Relationship between body mass index and gray matter volume in 1,428 healthy individuals | Q40130382 | ||
| Elevated serum levels of C-reactive protein are associated with mania symptoms in outpatients with bipolar disorder | Q40229306 | ||
| Amygdala and hippocampus volumes in pediatric major depression. | Q40460228 | ||
| Clinical importance of obesity versus the metabolic syndrome in cardiovascular risk in women: a report from the Women's Ischemia Syndrome Evaluation (WISE) study. | Q40530902 | ||
| Neuron numbers and volume of the amygdala in subjects diagnosed with bipolar disorder or schizophrenia | Q42517504 | ||
| Val66Met polymorphism and serum brain-derived neurotrophic factor in bipolar disorder: an open-label trial. | Q42614417 | ||
| A brief motivational intervention for preventing medication-associated weight gain among youth with bipolar disorder: treatment development and case report | Q42751743 | ||
| A high-fat diet impairs neurogenesis: Involvement of lipid peroxidation and brain-derived neurotrophic factor | Q42952281 | ||
| Patients taking medications for bipolar disorder are more prone to metabolic syndrome than Korea's general population | Q42990414 | ||
| High-fat diets induce a rapid loss of the insulin anorectic response in the amygdala | Q43281820 | ||
| Oxidative stress and lowered total antioxidant status are associated with a history of suicide attempts | Q43440072 | ||
| Prevalence of obesity and weight change during treatment in patients with bipolar I disorder | Q43642752 | ||
| Evidence of white matter pathology in bipolar disorder adolescents experiencing their first episode of mania: a diffusion tensor imaging study | Q43868614 | ||
| A cohort study of the prevalence and impact of comorbid medical conditions in pediatric bipolar disorder | Q43966075 | ||
| Distribution of the glucocorticoid receptor in the human amygdala; changes in mood disorder patients | Q44164854 | ||
| Obesity as a correlate of outcome in patients with bipolar I disorder | Q44265285 | ||
| The association between childhood adversity and components of metabolic syndrome in adults with mood disorders: results from the international mood disorders collaborative project. | Q44942294 | ||
| Increased oxidative stress in the anterior cingulate cortex of subjects with bipolar disorder and schizophrenia. | Q45923132 | ||
| GLP-1 responses are heritable and blunted in acquired obesity with high liver fat and insulin resistance. | Q46077822 | ||
| Amygdala modulation of parahippocampal and frontal regions during emotionally influenced memory storage | Q46437774 | ||
| The use of statins after a cardiac intervention is associated with reduced risk of subsequent depression: proof of concept for the inflammatory and oxidative hypotheses of depression? | Q46490022 | ||
| Reduced amygdalar gray matter volume in familial pediatric bipolar disorder | Q46503065 | ||
| White matter microstructural abnormalities in euthymic bipolar disorder | Q46625433 | ||
| Metabolic syndrome in bipolar disorder: findings from the Bipolar Disorder Center for Pennsylvanians | Q46714706 | ||
| Selective deletion of Bdnf in the ventromedial and dorsomedial hypothalamus of adult mice results in hyperphagic behavior and obesity. | Q46832215 | ||
| P433 | issue | 11 | |
| P407 | language of work or name | English | Q1860 |
| P921 | main subject | bipolar disorder | Q131755 |
| neurotoxicity | Q3338704 | ||
| P304 | page(s) | 987-1006 | |
| P577 | publication date | 2013-11-06 | |
| P1433 | published in | Advances in Therapy | Q4686392 |
| P1476 | title | Obesity and bipolar disorder: synergistic neurotoxic effects? | |
| P478 | volume | 30 |
| Q39690871 | A cluster analytic approach to identifying predictors and moderators of psychosocial treatment for bipolar depression: Results from STEP-BD. |
| Q47850636 | Adverse effects of obesity on cognitive functions in individuals at ultra high risk for bipolar disorder: Results from the global mood and brain science initiative. |
| Q38378743 | Are medical comorbid conditions of bipolar disorder due to immune dysfunction? |
| Q37236649 | Body mass index and psychiatric disorders: a Mendelian randomization study |
| Q48204136 | Comparison of pro-inflammatory cytokines among patients with bipolar disorder and unipolar depression and normal controls |
| Q89057805 | Differential Impact of Obesity on CD69 Expression in Individuals with Bipolar Disorder and Healthy Controls |
| Q36834290 | Obesity, but not metabolic syndrome, negatively affects outcome in bipolar disorder |
| Q36417680 | Rapid adipose deposition with mood disorders |
| Q30234571 | Systematic assessment of environmental risk factors for bipolar disorder: an umbrella review of systematic reviews and meta-analyses |
| Q38673546 | Treating to target in major depressive disorder: response to remission to functional recovery |
Search more.